Industries · Life Sciences
Turning Great Science Into Great Companies
Life Sciences | Biopharma | Medical Devices
We help founders accelerate the science while we handle the company-building — finance, clinical strategy, and capital, all under one roof.
What Life Science Founders Deal With
Most founders drown in company-building while they need to accelerate their science.
Clinical Execution Gaps
CRO overcharges, delayed site activations, and poor trial design drain programs before key data readouts.
Investor Unreadiness
Messy books, no milestone model, and a data room assembled weeks before the pitch. Investors notice.
Operational Blind Spots
Wrong hires, missed regulatory windows, IP structuring errors. The science is right; the company isn't.
Expert Gaps at the Wrong Time
You need a CMO strategist or grant specialist for a few months, not full-time, and can't find one fast enough.
Market Access Confusion
Reimbursement strategy, pricing, payer engagement, all deferred until commercialization, when it's too late.
Capital Strategy Misaligned
Equity vs. non-dilutive tradeoffs, grant timing, and round sizing decisions made reactively rather than by design.
Goodbye Consulting. Welcome Embedded Operators.
Zenith's forward-deployed operators work inside your organization, not alongside it.
The Old Way
Zenith
Sends a memo, then leaves
Joins your team and executes
Fills gaps after you feel them
Deploys ahead of every milestone
One generic playbook for everyone
Matched to your exact stage
Hands off at the finish line
Arrives with real relationships
You Handle the Science. We Handle the Rest.
Strategy, clinical, and commercial — all connected, all accountable, all under one roof.
ESTABLISH
Pre-Seed · IND Filing
Build before you raise.
- Financial architecture & investor-ready models
- Grants, non-dilutive capital strategy
- Ops, governance & organizational design
ACCELERATE
Series A · Phase I–II
Every dollar mapped to a milestone.
- Clinical strategy, CRO selection & oversight
- Regulatory pathway & filing support
- Program management & medical writing
COMMERCIALIZE
Series B · Pre-NDA & Exit
Approval is not the exit. We start earlier.
- Market access, payer strategy & pricing
- KOL engagement & brand positioning
- M&A readiness, partnership & BD
Forward Deployed Operators, Matched to Your Stage
From scientific validation and clinical strategy to fundraising, market access, and scale.
Operations & Finance
Investor-ready finance, compliant operations, and diligence-ready infrastructure.
Grants & Non-Dilutive Capital
Identify, secure, and manage grants that extend runway without dilution.
Clinical Strategy
Design milestone-driven clinical programs aligned with regulatory and investor expectations.
Strategic Advisory
Board-level strategy with operator-led execution across science and capital.
Organizational Build
Source and deploy the right leadership and specialists at every stage.
Market Intelligence
Map markets, competitors, and investor dynamics to drive confident decisions.
Partnership & BD
Secure licensing, strategic partnerships, and commercial opportunities.
Global Market Access
Navigate reimbursement, regulation, and international market expansion.
Commercial Launch
Build go-to-market, KOL, access, and positioning strategies for commercialization.
Specific deliverables. Outcomes your investors will see on day one of diligence.
Before You Raise
- Clinical trial financial model
- Diligence-ready data room
- Milestone-mapped runway model
- Non-dilutive capital strategy
While You're Building
- CRO contract review and audit
- Protocol design review
- IND strategy document
- Grant application support
When You're Ready to Raise
- Investor narrative and materials
- Warm introductions matched by stage and therapeutic area
- CRO selection shortlist
- Investor-ready data room
Results
Supported a pre-Series A biotech in closing their round ahead of schedule by rebuilding their clinical trial financial model and investor narrative.
Identified significant cost savings in a CRO contract before signing, and recovered additional costs mid-trial through renegotiation.
Selected Engagements
25M
Helped a biotech company raise 25M in Series B funding.
15M
Helped a MedTech company raise 15M in capital through HIPAA compliance consulting and regulatory structuring.
Let's Turn Your Science Into a Great Company.
We speak the language of science and capital.
Life Sciences
Biotech startups, research platforms, and translational science companies turning discovery into product.
Biopharma
Preclinical and clinical-stage companies navigating regulatory pathways, CMC, and capital strategy.
Digital Health
Healthtech, telemedicine, and AI-driven diagnostics building scalable, compliant revenue models.
Medical Devices
From concept to commercialisation — financial roadmaps for R&D-heavy device development.
One partner for finance and strategy.
- CFO function built for R&D-stage and revenue-stage life sciences companies
- Clinical trial budgeting, burn-rate forecasting, and milestone-based capital planning
- Regulatory pathway financial modelling — FDA and EMA submissions
- Investor readiness for venture, corporate venture, and strategic pharma partnerships
- Valuation support for licensing deals, co-development agreements, and M&A exits